HSP27 is a ubiquitin-binding protein involved in I-κBα proteasomal degradation

Arnaud Parcellier, Elise Schmitt, Sandeep Gurbuxani, Daphné Seigneurin-Berny, Alena Pance, Aurélie Chantôme, Stéphanie Plenchette, Saadi Khochbin, Eric Solary, Carmen Garrido

    Research output: Contribution to journalArticlepeer-review

    290 Citations (Scopus)

    Abstract

    HSP27 is an ATP-independent chaperone that confers protection against apoptosis through various mechanisms, including a direct interaction with cytochrome c. Here we show that HSP27 overexpression in various cell types enhances the degradation of ubiquitinated proteins by the 26S proteasome in response to stressful stimuli, such as etoposide or tumor necrosis factor alpha (TNF-α). We demonstrate that HSP27 binds to polyubiquitin chains and to the 26S proteasome in vitro and in vivo. The ubiquitin-proteasome pathway is involved in the activation of transcription factor NF-κB by degrading its main inhibitor, I-κBα. HSP27 overexpression increases NF-κB nuclear relocalization, DNA binding, and transcriptional activity induced by etoposide, TNF-α, and interleukin 1β. HSP27 does not affect I-κBα phosphorylation but enhances the degradation of phosphorylated I-κBα by the proteasome. The interaction of HSP27 with the 26S proteasome is required to activate the proteasome and the degradation of phosphorylated I-κBα. A protein complex that includes HSP27, phosphorylated I-κBα, and the 26S proteasome is formed. Based on these observations, we propose that HSP27, under stress conditions, favors the degradation of ubiquitinated proteins, such as phosphorylated I-κBα. This novel function of HSP27 would account for its antiapoptotic properties through the enhancement of NF-κB activity.

    Original languageEnglish
    Pages (from-to)5790-5802
    Number of pages13
    JournalMolecular and Cellular Biology
    Volume23
    Issue number16
    DOIs
    Publication statusPublished - 1 Jan 2003

    Cite this